Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact in Hartford
09:00am, Wednesday, 10'th Sep 2025
Grants will support local nonprofits improving health outcomes across the Greater Hartford area HARTFORD, Conn. , Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today tha
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact across Rhode Island
09:00am, Wednesday, 10'th Sep 2025
Grants will support local nonprofits improving health outcomes across the state WOONSOCKET, R.I. , Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today that it is awardin
Stock Of The Day: Is CVS Headed Higher?
03:16pm, Tuesday, 09'th Sep 2025
CVS Health Corporation CVS is trading higher on Tuesday. This follows yesterday's sell-off of almost 5%.
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
10:31am, Tuesday, 09'th Sep 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
S&P 500 Gains and Losses Today: Uber Stock Drives Higher; CVS Slides
06:25pm, Monday, 08'th Sep 2025
Major U.S. equities indexes ticked higher as markets kicked off a new trading week.
CVS Health Trades Cheaper Than Industry: How to Play the Stock?
09:40am, Monday, 08'th Sep 2025
CVS' diversified model, digital push and Aetna stabilization highlight a compelling investment story.
UnitedHealth price target raised to $362 from $337 at Barclays
06:24am, Thursday, 04'th Sep 2025
Barclays analyst Andrew Mok raised the firm's price target on UnitedHealth to $362 from $337 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care a
Molina Healthcare price target lowered to $185 from $186 at Barclays
06:24am, Thursday, 04'th Sep 2025
Barclays lowered the firm's price target on Molina Healthcare to $185 from $186 and keeps an Equal Weight rating on the shares. The firm adjusted estimates and targets in the managed care and healthca
Humana price target raised to $325 from $275 at Barclays
06:24am, Thursday, 04'th Sep 2025
Barclays analyst Andrew Mok raised the firm's price target on Humana to $325 from $275 and keeps an Equal Weight rating on the shares. The firm adjusted estimates and targets in the managed care and h
Elevance Health price target raised to $373 from $327 at Barclays
06:23am, Thursday, 04'th Sep 2025
Barclays raised the firm's price target on Elevance Health to $373 from $327 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare fa
CVS Health price target raised to $87 from $80 at Barclays
06:23am, Thursday, 04'th Sep 2025
Barclays analyst Andrew Mok raised the firm's price target on CVS Health to $87 from $80 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and h
Cigna price target raised to $383 from $354 at Barclays
06:23am, Thursday, 04'th Sep 2025
Barclays raised the firm's price target on Cigna to $383 from $354 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare facility gro
Centene price target lowered to $33 from $45 at Barclays
06:22am, Thursday, 04'th Sep 2025
Barclays analyst Andrew Mok lowered the firm's price target on Centene to $33 from $45 and keeps an Equal Weight rating on the shares. The firm adjusted estimates and targets in the managed care and h
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®
08:30am, Wednesday, 03'rd Sep 2025
CVS Health ® survey finds more than 60 percent of consumers say they are likely to get a flu shot this season Enhanced flu testing and treatment offerings are also available in select CVS Pharmacy
Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy
03:45pm, Tuesday, 02'nd Sep 2025
Healthcare investing has felt like walking through quicksand this year.
